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Background. Hand functionality and finger dexterity are impaired in patients with Parkinson’s disease (PD). )ese disturbances
lead to a dependency in activities of daily living (ADL) and poor quality of life (QoL). Objective. We aimed to evaluate whether a
specific occupational therapy (OT) program is effective in improving finger and hand dexterity and its impact on ADL in PD
patients. Methods. We retrospectively studied PD patients, hospitalized for a 4-week multidisciplinary intensive rehabilitation
treatment (MIRT) between January 2015 and June 2018. All patients underwent 1 h/day OT treatment, 5 days a week.)e primary
outcomemeasure was the O’Connor finger dexterity test; secondary outcomemeasures were theMinnesota dexterity test, UPDRS
II, and Self-Assessment Parkinson’s Disease Disability Scale (SPDDS). )ese measures were assessed at admission (T0) and
discharge (T1). Results. Based on the Hoehn and Yahr scale (H&Y), patients were divided into two groups: 262 subjects in H&Y
stage <3 (early-stage PD patients) and 220 in H&Y stage ≥3 (medium-advanced stage PD patients). As expected, at baseline, all
measures were worse in higher H&Y stages. After treatment, both groups experienced significant improvements in all outcomes.
Significant differences between early-stage and medium-advanced stage PD patients were observed only for the changes in
UPDRS II, with a better improvement in patients in H&Y stage ≥3. Conclusions. We showed that PD patients who underwent a
rehabilitation protocol including OTexperienced improvements in finger dexterity and hand functionality. Our results underline
the relevance of OT in improving autonomy and QoL in PD patients.
1. Introduction
Hand dysfunction is a common symptom in Parkinson’s
disease (PD) and is characterized by (i) poor manual dex-
terity, (ii) deficits in fine motor movements, (iii) inability to
control grip force output, and (iv) difficulty in performing
movements with normal amplitude, speed, and coordination
[1, 2].
Hand dysfunction leads to difficulties in activities of
daily living (ADL), such as eating, dressing, washing, and
writing [3], with loss of independency and poor quality of
life (QoL).
)ese abilities are acquired through motor learning
processes that are related to executive functions [4, 5].
Despite the presence of deficits in hands functionality
and the reduced autonomy in ADL [6], these disturbances
are often ignored because the majority of rehabilitation
programs are focused on gait and balance problems [7, 8].
)erefore, patients are usually referred to an occupational
therapist in the later disease stages, when they are experi-
encing a significant level of disability [9–11].
Only few studies have evaluated the effectiveness of
occupational therapy (OT) for patients with PD [12]. Several
multidisciplinary rehabilitative treatments designed for
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Parkinsonian patients have been shown to be effective in
reducing PD symptoms and improving motor functions
[8, 13–15].
OT aims at treating hand impairment to reduce de-
pendency or recover the patients’ autonomy in ADL [6, 9],
and it should be considered as an important aspect of a
multidisciplinary approach.
No previous studies have investigated the effectiveness of
an intensive, hand-based OT treatment, designed as a part of
a multidisciplinary-integrated approach, on hand func-
tionality and autonomy in daily living in patients with PD.
We aimed to evaluate whether (i) a specific OT is
effective to improve finger and hand dexterity in PD
patients, (ii) the effects of OT differ among patients at
different disease stages, and (iii) a better hand function
leads to improvements in personal autonomy.
2. Materials and Methods
2.1. Study Design and Participants. We retrospectively
identified PD patients, hospitalized at the Department of
Parkinson’s disease and Movement Disorder Rehabilitation
of “Moriggia-Pelascini” Hospital in Gravedona ed Uniti
(Como, Italy), from January 2015 to June 2018, to undergo a
4-week Multidisciplinary Intensive Rehabilitation Treat-
ment (MIRT) [14, 15].
Eligibility criteria were as follows: (1) diagnosis of id-
iopathic PD according to the UK Brain Bank criteria
[16]; (2) Hoehn and Yahr (H&Y) stage 2 to 4; (3) ability
to perform both the O’Connor finger dexterity test [17]
and the Minnesota manual dexterity test [18].
Exclusion criteria were as follows: (1) diagnosis of
atypical parkinsonisms, (2) psychosis, (3) auditory and
visual dysfunctions, and (4) comorbidities impairing
autonomy in ADL.
)e study design and protocol were approved by the
local Ethics Committee (“Comitato Etico Interaziendale
delle Province di Lecco, Como e Sondrio”) and were in
accordance with the code of Ethics of the World Medical
Association (Declaration of Helsinki, 1967). All patients
signed an informed written consent form for the use of their
clinical data for scientific purposes. )is trial was registered
on ClinicalTrials.gov website NCT03763955.
2.2. Outcome Measures
2.2.1. Primary Outcome Measure
(1) O’Connor Finger Dexterity Test. )e O’Connor finger
dexterity test (O’CT) is a peg-placement test that has been
used to evaluate the rapid manipulation of small objects. It
consists of a Masonite board with a moulded surface con-
sisting of 100 holes (each measuring 0.47 cm in diameter)
arranged in ten rows, each containing ten holes. Holes are
spaced 1.26 cm apart. )ree-hundred and fifteen pins
(length 2.54 cm; diameter 0.16 cm) lay in a well. )e subject
is required to fill each hole with 3 pins as fast as possible
using his/her dominant hand. Time elapsed for filling the
first half of the board (5 rows and 50 holes) is recorded in
seconds and then summed to the time elapsed for filling the
second half of the board (5 rows and 50 holes). )e number
of seconds taken to fill the second half of the board is
multiplied by 1.1. )e mean of this value and the number of
seconds taken to fill the first half of the board are computed,
i.e., raw score� (time for first 50 holes + (time for second half
holes x 1,1))/2.
)e test is considered as invaluable when patients need
more than 15 minutes to fill the first five rows. )e lower the
score obtained by the patient, the better his/her clinical
conditions. )e O’Connor test was administrated by an
occupational therapist at T0 (admission) and T1 (discharge,
4 weeks after T0).
2.2.2. Secondary Outcome Measures
(1) MinnesotaManual Dexterity Test. )eMinnesota manual
dexterity test (MMDT) investigates reach-to-grasp move-
ments, gross manual dexterity, and left vs right hand im-
pairment through a both-hand handling task. )e MMDT
includes two test batteries: placing test and turning test.
Placing test is performed with the dominant hand: it consists
of placing 60 black and red plastic disks into a grid of four
rows and aims at evaluating the upper limb speed in reach-
to-grasp movements and the gross hand ability to manip-
ulate object. In the turning test, the subject is asked to pick
up, turn upside down, and put down each disk in the grid:
these actions have to be performed by using one hand to pick
it up and the other one to turn it upside down and put it back
into the grid; the first part of the test (first two rows) is
performed using the same turning hand, while in the second
part (last two rows), subjects are requested to switch the
hands’ roles. )e aim of the turning test is to evaluate the
coordination skills and to highlight the difference between
the affected limb and the unaffected one, by testing them
during a both-hand handling task; the score is expressed in
seconds. )e lower the score obtained by the patient, the
better his clinical conditions.
MMDT was administrated by an occupational therapist
at T0 (admission) and T1 (discharge, 4-week after T0).
(2) SPDDS (Self-Assessment Parkinson’s Disease Disability
Scale) [19]. )e SPDDS is a self-assessment, patient-centred
questionnaire, aimed at measuring the disability in daily life
of patients with PD. )e questionnaire score ranges from 25
to 125 points. )e lower the score, the better the clinical
conditions. SPDDS was collected at T0 (admission) and T1
(discharge, 4-weeks after T0).
(3) UPDRS (Unified Parkinson’s Disease Rating Scale) [20].
)e UPDRS is the most used scale to assess the clinical
severity of PD. It consists of four sections: I: mentation,
behaviour, and mood (4 items); II: ADL (13 items); III:
motor examination (14 items); and IV: complications of
therapy (11 items). )e UPDRS was applied by a neurologist
with experience in movement disorders at T0 (admission)
and T1 (discharge, 4-weeks after T0). )e lower the score,
the better the clinical conditions.
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2.3. Neuropsychological Assessment. At admission, a neu-
ropsychologist assessed the patients’ cognitive profile using
the frontal assessment battery (FAB), a test designed for
evaluating executive functions (normal> 14 points).
2.4. QoL Assessment. At admission, patients were required
to fill in the self-administered Parkinson disease’s Ques-
tionnaire 39 (PDQ39), a questionnaire specifically designed
to assess quality of life [21]. )e lower the score, the better
the clinical conditions.
2.5. Interventions
2.5.1. MIRT Protocol. MIRT is a multidisciplinary, in-
tegrated, aerobic, motor-cognitive, intensive, and goal-based
rehabilitation treatment specifically designed for patients
with PD [13–15]. )e aim of the treatment is to relearn the
dysfunctional movements resulting from the disease
through the use of explicit and implicit learning strategies. It
consists of a 4-week program in a hospital setting, composed
of four different rehabilitative sessions from Monday to
Friday and 1 hour of physical exercise on Saturday. On
Sunday, the patients have a rest day. )e duration of each
session, including recovery periods, is about 1 hour:
(1) )e first session consists of a one-to-one treatment
with a physical therapist. It includes cardiovascular
warm-up activities, active and passive exercises to
improve joints’ range of motion, stretching of the
abdominal muscles, strengthening of paravertebral
muscles, postural changes, and exercises operating
on balance and postural control.
(2) During the second session, patients are trained with
different devices to improve gait and balance: a
stabilometric platform with a biofeedback [22], a
treadmill plus [23] (treadmill training with visual
cues, auditory cues and feedback), a crossover [22],
and a cycloergometer with feedback. We use a
maximum treadmill speed of 3.5 km/hour; patients
are trained with treadmill two times per day and each
session lasts no more than 15 minutes.
(3) )e third is an OT session (see section 2.5.2).
(4) )e fourth session includes 1 hour of speech therapy
[24].
)e rehabilitation program might include hydrotherapy,
robotic-assisted walking training, virtual reality training,
and psychoeducational groups. During the activities, the
heart rate reserve is kept between 70% and 80%.
Weekly team meetings are scheduled to tune the re-
habilitation programme for each patient and to assess its
benefits during the course of hospitalisation.
2.5.2. Occupational 8erapy Session. )eOTsession consists
of a group session (1 h/day with no more than 5 patients per
session) conducted and monitored by an occupational ther-
apist, which tailors the rehabilitative project taking into ac-
count patients’ individual motor and cognitive residual
abilities. OT is centred on the difficulties encountered by the
subject in everyday life. During the training sessions, patients
undergo functional and goal-based exercises aimed at
readapting the use of daily tools on the basis of their residual
abilities and relearning how to perform everyday tasks for
increasing personal autonomy. To enhance the hand func-
tionality and the motor control of hand movements, every OT
session is focused on finger and hand dexterity and co-
ordination and dual tasking skills. )e exercises are mainly
designed to intervene on the side (hand) most affected by the
disease, as well as on strategies for enhancing both-hands
handling coordination. For this reason, a useful method
adopted to intervene on the hand movements and func-
tionality is the writing-skill training: it consists of pencil-and-
paper exercises in which visual cues and verbal strategies are
used to achieve an enlargement of letter size and improve the
text readability. )e rehabilitation protocol exploits motor,
cognitive, and behavioural strategies and allows training of
patients’ awareness about their self-management potentialities
in everyday life. For this reason, patients are asked to learn and
perform simple exercises feasible also at home. Lastly, the
occupational therapist explains the caregivers how to interact
with the patient in the daily living to promote the subject’s
autonomy and increase their safety level.
2.6. Statistical Analysis. Descriptive statistics are reported as
mean± SD for continuous data and as number and percentage
frequency for discrete variables. )e Shapiro–Wilk test,
supported by visual inspection, was used to assess the nor-
mality of the distribution of continuous variables. Since most
outcomemeasures severely violated the normality assumption,
nonparametric statistics were used. Accordingly, between- and
within-group comparisons for continuous variables were
performed by the Mann–Whitney U test and Wilcoxon
signed-rank test, respectively. Comparisons of categorical
variables were carried out with the chi-squared test or Fisher’s
exact test when appropriate.
We first compared the outcome variables at discharge with
values at admission to assess the effect of MIRTon the overall
population.)e association between improvement in outcome
measures (difference between values at discharge and values at
admission) and demographic and clinical variables was in-
vestigated by Spearman’s rank correlation coefficient. To
further investigate whether MIRT affects positively the re-
habilitation outcome and determine the benefit regardless of
the patients’ stage of disease (early-medium or advanced), we
grouped patients according to H&Y< 3 or H&Y≥ 3 and
compared between-group improvement.
All statistical tests were two-tailed, and statistical signifi-
cance was set atp< 0.05.When appropriate, false discovery rate
was controlled at 5% using the Benjamini–Hochberg method.
All analyses were carried out using the SAS/STAT statistical
package, release 9.2 (SAS Institute Inc., Cary, NC, U.S.A.).
3. Results
)e study population consisted of 482 patients; among them,
262 were in H&Y stage <3 and 220 were in H&Y stage ≥3.
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Demographical, neuropsychological data and amount of
l-dopa equivalent dosage (LED) for the overall population
and for both groups of patients are reported in Table 1. As
expected, patients’ mean age, LED, disease duration, and
PDQ39 increased (i.e., worsened) passing from lower to
higher H&Y stages, while years of education and FAB de-
creased (i.e., worsened).
In Table 2, the values of the clinical, motor, and func-
tional outcome variables at baseline for all patients as a
whole and grouped in H&Y< 3 and in H&Y stage ≥3 are
reported, with p values for between-group comparisons. As
expected, all outcomes at baseline significantly worsened
passing from lower to higher H&Y stage (p< 0.0001 all, after
Benjamini–Hochberg adjustment).
Table 3 reports the differences (values at dis-
charge—values at admission) of the outcome measures.
AfterMIRT, all outcomemeasures improved (i.e., decreased,
for all these measures, the lower the better) significantly (i.e.,
the difference was significantly different from 0) in the
overall population and in both groups of patients (adjusted
p< 0.0001 all).
Comparing the amount of improvement in the two
groups, significant differences were observed only for the
changes in UPDRS II (adjusted p< 0.0001), with a better
improvement in more advanced H&Y stages (− 4.9± 2.5 vs
− 3.9± 2.1).
Correlation analysis revealed that the improvement in
outcome measures assessing dexterity was not associated
with H&Y stage, age, FAB, and PDQ39 (all adjusted p values>0.1). )e improvement in UPDRS II was associated with
H&Y stage, PDQ39 (adjusted p values <0.001 both), and
with FAB (adjusted p values� 0.02), while no significant
association was observed between SPDDS and H&Y stage,
age, FAB, and PDQ39.
Finally, subdividing all patients based on the side of motor
symptoms predominance (Table 4), we found differences
between groups at T0 (nor at T1), only in placing test part 2
and total score (p � 0.042 and p � 0.036, respectively).
4. Discussion
)is is the first study to evaluate the efficacy of a specific OT
intervention, designed as part of a multidisciplinary, in-
tensive, and integrated rehabilitation treatment, on hand
functionality, and autonomy in ADL in people with PD. Our
results indicate that both patients in early and in medium-
advanced H&Y stage obtained benefits from OT, as they
improved in fine hand movements, coordination, and au-
tonomy in daily living.
Benefits in finger dexterity (evaluated with O’CT), as well as
in hand dexterity and upper limb motor function (evaluated
with MMDT), were observed. In a previous study, Taghizadeh
and colleagues [25] investigated the effects of a sensory-motor
training (2 week-treatment, 2 hours/day for 5 days/week) on
hand and upper extremities in 50 PD patients (H&Y stage 1–3),
showing that the treatment was effective. Lee and colleagues
[26] reported improvements in fine and gross motor perfor-
mances of the upper limb in PDpatients (H&Y stage 2-3) after a
4-week period (3 hours/day for 5 days/week) of constraint-
induced movement therapy. Mateos-Toset and colleagues in
2015 [27] demonstrated in 60 PD patients (H&Y stage 2-3) an
improvement in manual dexterity and strength also after a
single 15-minute hand-exercise session. Our results confirm
that a goal-based, motor-cognitive training leads to improve-
ments in hand and finger dexterity in PD patients [28].
We also found that both patients with right- and left-side
motor symptoms predominance showed similar perfor-
mances at the beginning of the treatment and gained similar
benefit at discharge. Since 97% of our sample was composed
of right-handed persons and the primary outcome measure
(O’CT) was determined using the dominant hand, our data
suggest that finger and hand dexterity are impaired in the
dominant hand, regardless of the side of motor symptoms
predominance. )is finding is in line with previous data,
showing that dopamine deficit in the right caudate correlates
with difficulty in bimanual hand movements [29].
Despite a Cochrane review concluded that the evidence
supporting the efficacy of OT in PD is insufficient [30],
previous studies supported this approach as effective in
reducing the functional impact of PD in daily life [9, 10].
Coherently, the improvements in UPDRS II and SPDDS
scores suggest that MIRT is effective in improving the au-
tonomy in daily living.
Our results differ from those obtained in other studies
assessing the effects of a low-intensity program of physio-
therapy and OT [11], thus underlining the importance of the
treatment-intensity and specificity to obtain significant re-
sults in PD rehabilitation [31].
Table 1: Patients’ demographical, clinical, and neuropsychological data.
Variable All H&Y< 3 H&Y≥ 3 p
Age (years) 67.1± 9.4 64.3± 10.2 70.3± 7.3 <0.0001
Male gender (%) 54.4 50.9 57.1 0.17
Right side (%) 55.3 47.8 61.6 0.004
Right-handed (%) 97.1 98.6 95.8 0.065
LED (mg) 618± 319 538± 294 711± 324 <0.0001
Disease duration (years) 8.9± 5.2 7.7± 5.0 10.2± 5.2 0.0002
H&Y 2.6± 0.5 2.2± 0.3 3.1± 0.3 <0.0001
Years of education 10.5± 4.4 11.0± 4.2 9.9± 4.6 0.002
FAB 13.9± 3.0 14.4± 2.8 13.2± 3.1 <0.0001
PDQ39 41.1± 22.1 34.8± 17.4 51.6± 24.9 <0.0001
LED: daily levodopa equivalent dose; H&Y: Hoehn and Yahr stage; FAB: frontal assessment battery; PDQ39: Parkinson disease’s Questionnaire 39.
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Table 4: Differences (values at discharge—values at admission) in MMDTand O’CT for patients grouped on the basis of the side of motor
symptoms predominance.
Variable All patients T0 Side left T0 Side right T0 All patients T1 Side left T1 Side right T1 p T0 p T1
O’CT 499.6 (487.4,511.8)
496.0 (477.0,
515.0)
498.3 (482.2,
514.4)
436.1 (424.7,
447.5)
434.7 (416.0,
453.3)
433.07 (418.6,
447.4) 0.82 0.62
MMDT placing test 1 103.5 (101.4,105.6)
101.2 (98.0,
104.4)
105.1 (102.1,
108.1)
94.0 (92.2,
95.9)
92.1 (89.6,
94.6) 95.2 (92.4, 98.0) 0.08 0.41
MMDT placing test 2 97.8 (95.7,99.9)
95.4 (92.3,
98.5)
99.7 (96.7,
102.7)
89.4 (87.7,
91.1)
87.4 (84.9,
90.0) 90.6 (88.1, 93.0) 0.042 0.14
MMDT placing test
total score
201.2 (197.0,
205.3)
196.2 (189.9,
202.5)
204.8 (199.0,
210.7)
182.9 (179.4,
186.3)
178.1 (173.3,
182.8)
185.8 (180.6,
191.0) 0.036 0.12
MMDT turning test 1 24.2 (23.4,24.9)
24.3 (23.0,
25.6)
23.8 (22.8,
24.7)
20.3 (19.8,
20.9)
20.4 (19.5,
21.2) 20.1 (19.4, 20.9) 0.89 0.76
MMDT turning test 2 25.6 (24.8,26.5)
25.8 (24.7,
27.0)
25.1 (23.9,
26.2)
21.7 (21.0,
22.4)
21.7 (20.8,
22.7) 21.5 (20.4, 22.6) 0.09 0.31
MMDT turning test 3 21.8 (21.2,22.5)
21.4 (20.4,
22.3)
21.9 (21.1,
22.8)
18.9 (18.4,
19.4)
18.8 (18.0,
19.5) 18.7 (18.0, 19.3) 0.34 0.80
MMDT turning test 4 22.9 (22.1,23.6)
23.0 (21.9,
24.2)
22.6 (21.6,
23.5)
19.7 (19.2,
20.3)
19.9 (19.1,
20.8) 19.5 (18.8, 20.2) 0.47 0.60
MMDT turning test
total score
94.2 (91.4,
96.9)
94.2 (90.0,
98.5)
93.3 (89.6,
96.9)
80.6 (78.4,
82.7)
80.6 (77.5,
83.7) 79.9 (76.9, 82.9) 0.58 0.67
O’CT (O’Connor finger dexterity test); MMDT (Minnesota manual dexterity test); reported p values are from the Mann–Whitney U test (p T0 and p T1,
between-group comparison, left-side vs right-side motor symptoms patients at T0 and at T1, respectively). Data are reported as mean (95% CI).
Table 2: Baseline values of the clinical, motor, and functional outcome variables for all patients as a whole and grouped in H&Y< 3 and in
H&Y stage ≥3, with p values for between-group comparisons.
Variable All patients T0 H&Y< 3 H&Y≥ 3 p
O’CT (s) 499.6± 133.4 466.9± 117.6 541.5± 141.1 <0.0001
MMDT placing test 1 (s) 103.5± 23.4 97.9± 18.7 110.3± 26.5 <0.0001
MMDT placing test 2 (s) 97.8± 23.3 92.8± 19.5 103.8± 26.0 <0.0001
MMDT placing test total score (s) 201.2± 45.9 190.3± 37.9 214.3± 51.1 <0.0001
MMDT turning test 1 (s) 24.2± 8.6 22.1± 6.3 26.7± 10.3 <0.0001
MMDT turning test 2 (s) 25.6± 9.5 23.2± 6.7 28.5± 11.5 <0.0001
MMDT turning test 3 (s) 21.8± 7.0 20.0± 5.6 24.1± 7.9 <0.0001
MMDT turning test 4 (s) 22.9± 7.8 20.9± 6.1 25.2± 9.1 <0.0001
MMDT turning test total score (s) 94.2± 30.2 86.0± 22.4 104.2± 35.3 <0.0001
UPDRS part II 14.3± 5.0 12.1± 4.0 16.8± 4.8 <0.0001
UPDRS part III 19.8± 5.5 17.9± 4.5 21.9± 5.8 <0.0001
SPDDS 72.0± 13.6 68.8± 12.6 75.8± 13.9 <0.0001
O’CT (O’Connor finger dexterity test); MMDT (Minnesota manual dexterity test); UPDRS (unified Parkinson’s disease rating scale); SPDDS (self-assessment
Parkinson’s disease disability Scale). Reported p values are from the Mann–Whitney U test (between-group comparison, H&Y≥ 3 vs H&Y< 3).
Table 3: Differences (values at discharge—values at admission) of the outcome measures.
Variable All patients H&Y< 3 T1-T0 H&Y≥ 3 T1-T0 p H&Y≥ 3 vs H&Y< 3
D O’CT (s) − 69.5 (− 76.0,− 62.9)‡ − 69.0 (− 76.7,− 61.3)‡ − 70.1 (− 81.3,− 58.8)‡ 0.88
D MMDT placing test 1 − 9.6 (− 10.8,− 8.3)‡ − 9.0 (− 10.4,− 7.6)‡ − 10.2 (− 12.4,− 8.0)‡ 0.34
D MMDT placing test 2 − 8.4 (− 9.8,− 7.0)‡ − 8.6 (− 10.2,− 7.0)‡ − 8.3 (− 10.7,− 5.8)‡ 0.83
D MMDT placing test total score − 18.5 (− 21.0,− 16.0)‡ − 17.2 (− 20.0,− 14.4)‡ − 20.0 (− 24.3,− 15.6)‡ 0.28
D MMDT turning test 1 − 3.9 (− 4.4,− 3.4)‡ − 3.7 (− 4.2,− 3.1)‡ − 4.2 (− 5.2,− 3.2)‡ 0.30
D MMDT turning test 2 − 4.2 (− 4.8,− 3.6)‡ − 3.7 (− 4.3,− 3.1)‡ − 4.8 (− 5.9,− 3.7)‡ 0.08
D MMDT turning test 3 − 3.0 (− 3.5,− 2.6)‡ − 2.9 (− 3.3,− 2.4)‡ − 3.3 (− 4.0,− 2.5)‡ 0.38
D MMDT turning test 4 − 3.2 (− 3.7,− 2.7)‡ − 2.9 (− 3.4,− 2.3)‡ − 3.6 (− 4.4,− 2.8)‡ 0.17
D MMDT turning test total score − 14.1 (− 15.7,− 12.5)‡ − 12.8 (− 14.5,− 11.0)‡ − 15.7 (− 18.6,− 12.8)‡ 0.08
D UPDRS part II − 4.4 (− 4.6,− 4.2)‡ − 3.9 (− 4.2,− 3.7)‡ − 4.9 (− 5.2,− 4.6)‡ <0.0001
D UPDRS part III − 6.0 (− 6.3,− 5.8)‡ − 5.8 (− 6.1,− 5.5)‡ − 6.2 (− 6.6,− 5.9)‡ 0.09
D SPDDS − 15.8 (− 16.6,− 15.1)‡ − 16.0 (− 17.0,− 15.1)‡ − 15.6 (− 16.8,− 14.5)‡ 0.62
O’CT (O’Connor finger dexterity test); MMDT (Minnesota manual dexterity test); UPDRS (unified Parkinson’s disease rating scale); SPDDS (self-assessment
Parkinson’s disease disability scale); D (delta). Reported p values are from the Mann-Whitney U test (between-group comparison, H&Y≥ 3 vs H&Y< 3).
‡p< 0.001, Wilcoxon signed-rank test testing H0: delta� 0 (within-subject). Data are reported as mean (95% CI). For all considered scores, a negative change
(i.e., a reduction after MIRT) is associated with an improvement.
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Strong correlations among hand dexterity, functional gains,
and improvements in both SPDDS and UPDRS II were found.
)is is an important perspective in terms of self-perceived QoL
that has been already been shown to improve after MIRT [32].
Our data confirm the efficacy of a multidisciplinary
rehabilitation treatment on patients with PD [13–15] and
highlight the contribution of hand training and OT.
In line with previous data [28, 33], we found a negative
correlation between all outcomes and cognitive status as
assessed by the FAB and a lack of association between
cognitive status and the size of the improvement after re-
habilitation. )is is a noteworthy aspect: although patients
with worse cognition are characterized by poorer motor
performances, the cognitive status does not hamper the
patients to achieve benefits after rehabilitation.
As expected, clinical conditions of patients in H&Y stage≥3 were worse than those in H&Y stage <3. However, at
discharge, patients in H&Y stage ≥3 showed a greater im-
provement in comparison with those in H&Y stage <3, likely
due to a “ceiling” effect. )ese data confirm that, even
though patients’ performances are influenced by their motor
and cognitive conditions, these aspects do not have a neg-
ative impact on rehabilitation outcomes [28, 33].
In conclusion, we showed that a specific OT in-
tervention, designed as part of a multidisciplinary, intensive,
and integrated rehabilitation treatment, is effective to im-
prove finger and hand dexterity and autonomy in activities
of daily living in PD patients, regardless of the disease se-
verity. Our results underline (i) the relevance of OT, often
neglected in the rehabilitative protocols for PD, and (ii) the
need to start this treatment as soon as possible to prevent or
delay disturbances of hand functioning.
)is study has some limitations that have to be ac-
knowledged: (i) the lack of a control group of patients
undergoing a conventional, nonintensive, nor goal-based
treatment and not including a specific OT program; (ii) we
did not collect follow-up data to evaluate whether and how
long the improvements observed in hand functionality and
ADL last. Further studies are needed to clarify these issues
and better clarify the role of OT in PD rehabilitation.
Data Availability
)e Excel file containing the data used to support the
findings of this study is available from the corresponding
author upon request.
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